Skip to main content

Table 1 Prevalence and incidence of rhGH treatment in SGA patients in Italy from 2011 to 2017, according to the National Registry of Growth Hormone therapy data

From: Practical tools to identify short children born small-for-gestational-age eligible for rhGH treatment according to Italian regulation

  Year  
2011 2012 2013 2014 2015 2016 2017 Mean ±DS
Prevalence
 SGA treated patients (n) 54 68 65 70 108 140 155   
 Prevalence (per 100,000 general population/year) 0.37 0.47 0.44 0.28 0.22 0.27 0.37 0.35 0.09
 Prevalence (per 100,000 0–15 years population/year) 0.61 0.76 0.72 0.78 1.22 1.60 1.79 1.07 0.47
Incidence
 New SGA treated patients (n) 39 29 30 30 47 49 39   
 Incidence (per 100,000 general population/year) 0.37 0.27 0.22 0.28 0.44 0.47 0.38 0.35 0.09
 Incidence (per 100,000 0–15 years population/year) 0.44 0.33 0.27 0.34 0.53 0.56 0.45 0.42 0.11